US stocks starting with L
The official accounts of 99 companies listed in the United States whose name starts with L: revenue and net profit for the latest fiscal year, as stated in the annual report (Form 10-K) each one files with the SEC, in US dollars. Each one links to its page, with the document every figure comes from.
| Company | Ticker | Fiscal year | Revenue | Net profit |
|---|---|---|---|---|
| L3Harris | NYSE: LHX | 2025 | — | $1,606m |
| LA-Z-BOY | NYSE: LZB | 2026 | $2,127m | $102.0m |
| Labcorp | NYSE: LH | 2025 | $13,952m | $876.5m |
| Ladder Capital | NYSE: LADR | 2025 | $266.9m | $63.7m |
| Lakeland Financial | NASDAQ: LKFN | 2025 | $269.0m | $103.4m |
| Lam Research | NASDAQ: LRCX | 2026 | $23,233m | $7,265m |
| Lamar Advertising | NASDAQ: LAMR | 2025 | $2,266m | $587.2m |
| Lamb Weston | NYSE: LW | 2026 | $6,612m | $290.0m |
| LandBridge | NYSE: LB | 2025 | $199.1m | $30.1m |
| Landmark Bancorp | NASDAQ: LARK | 2025 | $70.6m | $18.8m |
| Lands’ End | NASDAQ: LE | 2026 | $1,335m | $5.5m |
| Landstar System | NASDAQ: LSTR | 2025 | $4,744m | $115.0m |
| Lantheus | NASDAQ: LNTH | 2025 | $1,542m | $233.6m |
| Lantronix | NASDAQ: LTRX | 2026 | $120.9m | −$4.2m |
| Larimar Therapeutics | NASDAQ: LRMR | 2025 | — | −$165.7m |
| Las Vegas Sands | NYSE: LVS | 2025 | $13,017m | $1,627m |
| Latham Group | NASDAQ: SWIM | 2025 | $545.9m | $11.1m |
| Laureate Education | NASDAQ: LAUR | 2025 | $1,702m | $281.6m |
| Lazard | NYSE: LAZ | 2025 | $3,186m | $236.8m |
| LCI Industries | NYSE: LCII | 2025 | $4,122m | $188.3m |
| LCNB | NASDAQ: LCNB | 2025 | $92.0m | $23.1m |
| Lear | NYSE: LEA | 2025 | $23,259m | $436.8m |
| LEE Enterprises | NASDAQ: LEE | 2025 | $562.3m | −$37.6m |
| Legacy Housing | NASDAQ: LEGH | 2025 | $164.6m | $41.8m |
| LegalZoom.com | NASDAQ: LZ | 2025 | $756.0m | $15.4m |
| Leidos | NYSE: LDOS | 2025 | $17,174m | $1,448m |
| LeMaitre Vascular | NASDAQ: LMAT | 2025 | $249.6m | $57.7m |
| Lemonade | NYSE: LMND | 2025 | $737.9m | −$165.5m |
| LendingTree | NASDAQ: TREE | 2025 | $1,117m | $151.3m |
| Lennar | NYSE: LEN | 2025 | $34,187m | $2,078m |
| Lennox International | NYSE: LII | 2025 | $5,195m | $805.8m |
| LENZ Therapeutics | NASDAQ: LENZ | 2025 | $19.1m | −$82.1m |
| Leonardo DRS | NASDAQ: DRS | 2025 | $3,648m | $278.0m |
| LEVI Strauss | NYSE: LEVI | 2025 | $6,282m | $578.1m |
| Lexeo Therapeutics | NASDAQ: LXEO | 2025 | — | −$100.0m |
| Lexicon Pharmaceuticals | NASDAQ: LXRX | 2025 | $49.8m | −$50.3m |
| LGI Homes | NASDAQ: LGIH | 2025 | $1,706m | $72.6m |
| Liberty Energy | NYSE: LBRT | 2025 | $4,006m | $147.9m |
| Liberty Global | NASDAQ: LBTYA | 2025 | $4,879m | −$7,138m |
| Liberty Latin America | NASDAQ: LILA | 2025 | $4,442m | −$611.2m |
| Liberty Media | NASDAQ: FWONA | 2025 | $4,482m | $555.0m |
| Life Time Group | NYSE: LTH | 2025 | $2,995m | $373.7m |
| Life360 | NASDAQ: LIF | 2025 | $489.5m | $150.8m |
| Lifecore Biomedical | NASDAQ: LFCR | 2025 | $128.9m | −$38.7m |
| LifeMD | NASDAQ: LFMD | 2025 | $194.1m | $14.4m |
| LifeStance Health Group | NASDAQ: LFST | 2025 | $1,424m | $9.7m |
| Lifetime Brands | NASDAQ: LCUT | 2025 | $647.9m | −$26.9m |
| Lifeway Foods | NASDAQ: LWAY | 2025 | $212.5m | $13.9m |
| Ligand Pharmaceuticals | NASDAQ: LGND | 2025 | $268.1m | $124.5m |
| Lightbridge | NASDAQ: LTBR | 2025 | $0.0m | −$19.6m |
| Lightpath Technologies | NASDAQ: LPTH | 2026 | $71.7m | −$20.5m |
| Lightwave Logic | NASDAQ: LWLG | 2025 | $0.2m | −$20.3m |
| Limbach | NASDAQ: LMB | 2025 | $646.8m | $39.1m |
| Limoneira | NASDAQ: LMNR | 2025 | $159.7m | −$16.0m |
| Lincoln Educational Services | NASDAQ: LINC | 2025 | $518.2m | $20.0m |
| Lincoln Electric | NASDAQ: LECO | 2025 | $4,233m | $520.5m |
| Lincoln National | NYSE: LNC | 2025 | $18,212m | $1,177m |
| Lindblad Expeditions | NASDAQ: LIND | 2025 | $771.0m | −$29.7m |
| Linde | NASDAQ: LIN | 2025 | $33,986m | $6,898m |
| Lindsay | NYSE: LNN | 2026 | $635.9m | $55.7m |
| Lineage | NASDAQ: LINE | 2025 | $5,355m | −$100.0m |
| Lineage Cell Therapeutics | NYSE: LCTX | 2025 | $14.6m | −$63.5m |
| Lionsgate Studios | NYSE: LION | 2026 | $2,632m | −$198.3m |
| Liquidia | NASDAQ: LQDA | 2025 | $158.3m | −$68.9m |
| Liquidity Services | NASDAQ: LQDT | 2025 | $476.7m | $28.1m |
| Lithia Motors | NYSE: LAD | 2025 | $37,635m | $819.6m |
| Lithium Americas | NYSE: LAC | 2025 | — | −$86.3m |
| Littelfuse | NASDAQ: LFUS | 2025 | $2,386m | −$71.7m |
| LivaNova | NASDAQ: LIVN | 2025 | $1,388m | −$242.5m |
| Live Nation Entertainment | NYSE: LYV | 2025 | $25,201m | $496.0m |
| Live Oak Bancshares | NYSE: LOB | 2025 | $577.8m | $105.9m |
| LiveRamp | NYSE: RAMP | 2026 | $812.9m | $146.0m |
| LiveWire Group | NYSE: LVWR | 2025 | $25.7m | −$75.1m |
| LKQ | NASDAQ: LKQ | 2025 | $13,651m | $608.0m |
| loanDepot | NYSE: LDI | 2025 | $158.8m | −$62.6m |
| Loar | NYSE: LOAR | 2025 | $496.3m | $72.1m |
| Lockheed Martin | NYSE: LMT | 2025 | $75,048m | $5,017m |
| Loews | NYSE: L | 2025 | $18,454m | $1,667m |
| Logitech International | NASDAQ: LOGI | 2026 | $4,841m | $711.2m |
| Loma Negra | NYSE: LOMA | 2025 | ARS 848,087m | ARS 23,585m |
| Louisiana-Pacific | NYSE: LPX | 2025 | $2,708m | $146.0m |
| Lovesac | NASDAQ: LOVE | 2026 | $697.1m | $4.1m |
| Lowe's | NYSE: LOW | 2026 | $86,286m | $6,654m |
| LPL Financial | NASDAQ: LPLA | 2025 | $16,989m | $863.0m |
| LSB Industries | NYSE: LXU | 2025 | $615.2m | $24.6m |
| LSI Industries | NASDAQ: LYTS | 2026 | $689.4m | $22.6m |
| LTC Properties | NYSE: LTC | 2025 | $262.9m | $118.0m |
| Lucid Diagnostics | NASDAQ: LUCD | 2025 | $4.7m | −$58.0m |
| Lucid Group | NASDAQ: LCID | 2025 | $1,354m | −$2,698m |
| Lucky Strike Entertainment | NYSE: LUCK | 2026 | $1,245m | −$35.8m |
| Lululemon Athletica | NASDAQ: LULU | 2026 | $11,103m | $1,579m |
| Lumen Technologies | NASDAQ: LUMN | 2025 | $12,402m | −$1,739m |
| Lument Finance Trust | NYSE: LFT | 2025 | — | −$2.7m |
| Lumentum | NASDAQ: LITE | 2026 | $3,014m | −$6,935m |
| Luxfer | NYSE: LXFR | 2025 | $384.6m | $7.7m |
| LXP Industrial Trust | NYSE: LXP | 2025 | $350.2m | $113.2m |
| Lyell Immunopharma | NASDAQ: LYEL | 2025 | $0.0m | −$274.4m |
| Lyft | NASDAQ: LYFT | 2025 | $6,316m | $2,844m |
| LyondellBasell | NYSE: LYB | 2025 | $30,153m | −$738.0m |
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell.